Dr. Najahi-Missaoui’s areas of interest include nanoparticulate drug delivery systems such as liposomes to target therapies for cancers including prostate and breast cancers. Her overall goal is to integrate the pathophysiology of cancer with the pharmacology of these drug delivery systems to develop more efficient targeted cancer therapies.